Operating Income: The income after operating expenses.
Jasper Therapeutics, Inc. (JSPR) had Operating Income of $-27.08M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-26.72M |
|
-- |
|
-- |
|
$27.08M |
|
|
Operating Income |
$-27.08M |
$0.35M |
|
$-26.72M |
|
$-26.72M |
|
$-26.72M |
|
$-26.72M |
|
$-26.72M |
|
$-26.72M |
|
$-27.08M |
|
$-26.82M |
|
15.33M |
|
15.33M |
|
$-1.74 |
|
$-1.74 |
|
| Balance Sheet Financials | |
$42.97M |
|
$1.33M |
|
$3.50M |
|
$46.47M |
|
$20.50M |
|
-- |
|
$2.46M |
|
$22.96M |
|
$23.50M |
|
$23.50M |
|
$23.50M |
|
16.22M |
|
| Cash Flow Statement Financials | |
$-38.30M |
|
$0.01M |
|
$6.16M |
|
$72.05M |
|
$39.93M |
|
$-32.13M |
|
$3.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-38.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-113.71% |
|
-113.71% |
|
-57.51% |
|
-113.71% |
|
$1.45 |
|
$-2.50 |
|
$-2.50 |
|